Mark Piper

Co-Founder, CEO

Therapeutic Areas

Drug	Indication	Phase
ONO Transcatheter Retrieval System	Percutaneous removal of embolized/malpositioned cardiovascular devices (e.g., LAAO occluders)	Feasibility / First-in-Human